Can a 62-year-old woman with a family history of von Willebrand disease (VWD) still have the condition despite normal von Willebrand factor (VWF) activity to antigen ratio, given her low VWF levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Von Willebrand Disease in a 62-Year-Old Woman with Family History Despite Normal VWF Ratio

Yes, a 62-year-old woman with a family history of von Willebrand disease can still have the condition despite a normal VWF activity to antigen ratio of 1.0, especially if her VWF levels are low. 1

Diagnostic Considerations

Key Laboratory Findings

  • The initial VWD testing panel should include:
    • VWF antigen (VWF:Ag)
    • VWF activity (VWF:RCo or other platelet binding assay)
    • Factor VIII coagulant activity (FVIII)
    • Calculation of VWF:RCo/VWF:Ag ratio 2, 1

Why Low VWF with Normal Ratio Can Still Indicate VWD

  1. Type 1 VWD Possibility:

    • Type 1 VWD is characterized by partial quantitative deficiency of VWF
    • Can present with proportionally reduced VWF:Ag and VWF:RCo (maintaining a normal ratio) 3
    • Low VWF levels (30-50 IU/dL) can be clinically significant 4
  2. VWF as an Acute Phase Reactant:

    • VWF levels typically increase with age 1
    • The fact that this 62-year-old patient has low VWF levels despite her age is particularly concerning, as VWF levels should be higher in older individuals 1
    • VWF can be falsely elevated due to stress, inflammation, or other clinical conditions 1
  3. Variability in Testing:

    • A single normal test does not rule out VWD, especially with strong family history
    • Guidelines recommend repeat testing up to 3 times to ensure reliable results 1

Clinical Approach

Assessment Algorithm

  1. Evaluate Family History:

    • Confirmed family history of Type 2 VWD is highly significant
    • Consultation with a hematologist is recommended for patients with strong family history of VWD 1
  2. Additional Testing to Consider:

    • Complete VWD evaluation requires:
      • Multimer analysis
      • RIPA testing
      • VWF:CB (collagen binding) assays 1
    • These specialized tests can detect subtle abnormalities not apparent in basic testing 2
  3. Consider Low VWF as a Clinical Entity:

    • Patients with VWF levels between 30-50 IU/dL represent a diagnostic challenge
    • Some patients with "low VWF" have significant bleeding problems despite not meeting strict VWD criteria 4
    • Recent research suggests low VWF may be a complex disorder caused by variants in genes beyond VWF 4

Common Pitfalls and Caveats

  1. Relying on a Single Test:

    • A normal VWF:RCo/VWF:Ag ratio alone does not rule out VWD 1
    • VWF levels can fluctuate, requiring repeat testing 1
  2. Age Considerations:

    • VWF levels typically increase with age, so low levels in a 62-year-old are particularly noteworthy 1, 4
    • The discrepancy between expected age-related VWF increase and observed low levels strengthens the suspicion for VWD
  3. Mixed VWD Phenotypes:

    • Some VWF gene mutations can have complex effects and give rise to mixed VWD phenotypes 3
    • This can complicate diagnosis and classification
  4. Standardized Bleeding Assessment:

    • Use of a standardized bleeding assessment tool (BAT) is recommended to objectively quantify bleeding history 1
    • This can help correlate laboratory findings with clinical presentation

In conclusion, the combination of low VWF levels in a 62-year-old woman with a family history of VWD strongly suggests she may have VWD despite a normal VWF:RCo/VWF:Ag ratio. Further specialized testing is warranted, and consultation with a hematologist experienced in VWD diagnosis is recommended.

References

Guideline

Management of von Willebrand Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.